arrow
P

Peter G. Hains

childrens medical research institute
H指数:22
被引数:2,204

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Sulfonadyn Compounds: A Class of Aryl Sulfonamides That Inhibit Dynamin GTPase and Clathrin-Mediated Endocytosis and Are Antiepileptic in Animal Models

磺胺达尼化合物:一类抑制Dynamin GTPase和笼蛋白介导的内吞作用且在动物模型中具有抗癫痫活性的芳基磺酰胺类化合物

2026-06-180
PRE
Large-scale drug sensitivity, gene dependency, and proteogenomic analyses of telomere maintenance mechanisms in cancer cells

大规模药物敏感性、基因依赖性和蛋白质基因组学分析,探讨癌细胞中端粒维持机制

2025-12-230
OAAI
Proteomic-based stratification of intermediate-risk prostate cancer patients (vol 7, e202302146, 2023)

基于蛋白质组学的中危前列腺癌患者分层(vol 7, e202302146, 2023)

2025-12-010
OA
Can proteomics predict metastatic relapse in leiomyosarcoma (LMS)? Development of an 8 protein signature in a >350 sample study including a validation cohort

蛋白质组学能否预测子宫平滑肌肉瘤(LMS)的转移复发?一项包含验证队列的>350样本研究中的8蛋白标志物的开发

2024-09-010
PRE
Proteomic-based stratification of intermediate-risk prostate cancer patients

基于蛋白质组学的中危前列腺癌患者分层

2023-12-048
OAAI
A proteomic-based prognostic signature of pancreatic adenocarcinoma
2023-04-040
PRE
A six-protein signature predicts response and survival in patients with advanced cutaneous melanoma treated with immunotherapy
2023-04-040
PRE
Strategies to enable large-scale proteomics for reproducible research
2020-07-3082
OAAI